Why the study?
Do therapies for depression improve survival and reduce morbidity in depressed CAD patients?
Do therapies for depression improve survival and reduce morbidity in depressed CAD patients?
While depression is linked to adverse outcomes in CAD, there is currently insufficient evidence that treating depression improves clinical outcomes, highlighting the need for randomized trials.
Answers are grounded in this paper and cite their sources.
Depression interventions should not yet be assumed to improve CAD outcomes; leaves open whether RCTs can demonstrate survival or morbidity benefits.
There is substantial evidence for a relationship between depression and adverse clinical outcomes. However, despite the availability of effective therapies for depression, there is a paucity of data to support the efficacy of these interventions to improve clinical outcomes for depressed CAD patients. Randomized clinical trials are needed to further evaluate the value of treating depression in CAD patients to improve survival and reduce morbidity.
No takes yet. Share an insight, caveat, or question.
Heather S. Lett (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: